No Need To Envy Tax-Inversion Takeovers: Better Tax Deal Awaits

Watching big pharmaceutical companies and other major U.S. corporations line up to make foreign acquisitions that will bring them a low-tax haven as headquarters, a middle market CEO/owner/entrepreneur could easily become jealous. Are you feeling stuck with an effective tax rate of 25%, 30% or even 35%?

http://www.forbes.com/sites/maryjosephs/2014/07/22/no-need-to-envy-tax-inversion-takeovers-better-tax-deal-awaits/

About the Author

has written 23402 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com